Reducing Insulin Related Errors in Patients Treated for Hyperkalemia
|
|
|
- Louisa Blankenship
- 10 years ago
- Views:
Transcription
1 Reducing Insulin Related Errors in Patients Treated for Hyperkalemia Tan Tock Seng Hospital is an acute care general hospital with a 1,200 bed capacity The hospital addressed the problem of insulinrelated errors in patients treated for hyperkalemia using the Clinical Process Improvement Project (CPIP) methodology We wish to share their innovative solution of using a HIGH-K + pack to deal with this problem
2 Mission Statement All cases of hyperkalemia (serum K + > 6mmol/L) should have appropriate* Treatment Monitoring instituted within six hours of notification of hyperkalemia Time frame for implementation of project: Within 6 months
3 Appropriate Treatment To be started within an hour of hyperkalemia notification Correct indication (rule out pseudo-hyperkalemia) ECG and baseline capillary blood glucose(cbg) taken Stop all medications causing hyperkalemia IV Calcium Gluconate (ECG changes + Serum K + > 6.5mmol/L) IV Insulin 5-10 units + IV Dextrose Resonium IV Frusemide, if indicated
4 Appropriate Monitoring To be started within an hour of hyperkalemia notification Need for Telemetry or High Dependency stay (Serum K + >7 + ECG changes + muscle weakness + rising K + levels/other medical indication), Baseline CBG Hourly CBG for 6 hours after IV Insulin bolus Repeat ECG within 1 hour if ECG changes Repeat K + in 2 hours if ECG changes Repeat ECG in 4-6 hours if ECG normal Repeat K + in 4-6 hours if ECG normal Maintenance IV Dextrose infusion started if indicated
5 Team Members Team Leader Dr Julie George, Consultant, General Medicine Expert advisors Dr Alvin Tan, Consultant, Endocrinology Dr Jackie Tan, Head of Department, General Medicine Team Members Dr Aisah F, Medical Officer Dr Joel Lim, Resident, Dr Goh W Y, Resident, Sr Rusvinder Kaur, Nurse Clinician Ms Lim Chee Yuen, Pharmacist Ms Irene, SN, Ms Nor, SN
6 Evidence for Problem Worth Solving Sentinel Events Case 1 77-year-old Chinese male with history of hypertension, hyperlipidemia, Ischemic Heart Disease(IHD), peptic ulcer disease and renal impairment was admitted, via Emergency Department, with complaints of shortness of breath and bilateral lower limb weakness Patient was assessed as having an acute chronic renal failure and worsening IHD He was prescribed IV insulin 10 units in 40 ml Dextrose 50% solution House Officer (HO) inadvertently administered 100 units of insulin in 20 ml Dextrose 50% solution Patient was found unresponsive and glucometer showed patient was hypoglycemic He subsequently developed aspiration pneumonia secondary to coma and died
7 Evidence for Problem Worth Solving Sentinel Events.Case 2 House Officer administered IV insulin to patient as part of the management for hyperkalemia 60 units of insulin rather than the intended 6 units was administered as he assumed that 1unit of Insulin was equivalent to 1 large marking (5 small markings) on the insulin syringe
8 Evidence for Problem Worth Solving Sentinel Events.Case 3 Patient admitted for gastroenteritis associated with hyperkalemia He was prescribed 10 units of Insulin but the House Officer used a normal syringe and administered 8 mls on Insulin (equivalent to 800 units!) instead Patient developed hypoglycemia and was transferred to ICU but subsequently recovered
9 Evidence for Problem Worth Solving Sentinel Events.Case 4 Patient was admitted for treatment of hyperkalemia 8 units of Insulin were ordered House Officer drew the insulin into a 3ml syringe and administered entire volume of 3 ml to the patient intravenously Patient received 300 units instead of 8 units of Insulin!! She had 5 episodes of hypoglycemia which was treated with IV 50% Fortunately she recovered
10 Why Do Insulin-Related Errors Occur? Errors in Insulin Dosage Use of regular syringe to administer insulin Unfamiliarity with unit markings on insulin syringe Failure to monitor glucose levels following administration of insulin
11 Baseline data Baseline data of medical patients admitted in Nov 2010 and Jan 2011 for hyperkalemia: Total no of cases requiring insulin to correct hyperkalemia: 28 cases % of cases that received appropriate treatment: 78% % of cases that were monitored for hypoglycemia: 7%
12 Reasons for Inadequate Treatment & Monitoring of Patients with Hyperkalemia Protocol No existing protocol on treatment and monitoring of patients with hyperkalemia Training and Orientation No formal training and orientation for junior doctors on management of hyperkalemia Knowledge deficit Junior doctors were not familiar with insulin syringes and markings on insulin syringes
13 Interventions CAUSE INTERVENTIONS DATE OF IMPLEMENTATION No Protocol for Hyperkalemia Management Flow chart on acute management and monitoring of patients with hyperkalemia developed and placed in HIGH K + pack. Use of a stamp to assist nurses in documentation and monitoring needs of patients on treatment for hyperkalemia. 22 nd March rd May 2011 Lack of Training and Orientation Knowledge Deficit about Insulin Syringes Briefing for all Doctors and Nurses on Protocol for hyperkalemia management Training for all Doctors on use of Insulin syringes High K + pack Regular Insulin with tag to remind users to use insulin syringe. High K + pack stocked with insulin syringe. Regular Insulin with picture to show how dose should be drawn. 1 st March nd March 2011
14 Hyperkalemia Pack Hyperkalemia protocol Table of content Alcohol swabs Actrapid vial (tagged) Monitoring stamp Insulin syringes
15 Each Actrapid vial tagged
16 New Protocol for Treatment and Monitoring of Patients with Hyperkalemia New Protocol for treatment and management of hyperkalaemia S.K> 6mmol/L Hyperkaleamia Exclude pseudohyperkalaemia E.g. Hemolysis Repeat S. K Treatment Monitoring ECG + */ S.K >6.5 High risk patients: Acute renal failure/ ESRF on dialysis/ Coronary Artery Disease/ Acute Myocardial Injury 1.IV Calcium Gluconate 10 ml of 10% over 2-3 minutes ( slow infusion over 20 mins in 100mls of 5%Dextrose in patients on digoxin) Telemetry/bedside cardiac monitor/ hourly parameters( based on availability) or High Dependency monitoring if patient is unstable ECG, HC (Capillary blood ECG n/ S.K <6.5 glucose) 2.IV Insulin Regular 5-10 units + IV Dextrose 50% 40 mls bolus (Dextrose could be avoided if baseline HC>18mmol/L) Consider maintenance IV dextrose infusion* (if baseline HC <6 /NBM /Poor oral intake/ previous episodes of hypoglycemia*) 3.Resonium (PO gm or PR 30 gm) 4.Stop all IV/oral medications causing hyperkalaemia* 5.HC hourly for 6 hours Hourly parameters *Refer to details in medicine bulletin board Copyright TTSH, 2011 Repeat ECG in 10 mins to check for ECG resolution and at 30min-1 hour in patients who are not on telemetry Repeat dose of IV Calcium gluconate if ECG changes are persistent Telemetry/High dependency needed Repeat S.K+in 2 hours Repeat S.K+ and ECG in 4-6 hours Persistent hyperkalaemia 1.Repeat steps Consider IV Lasix ( with residual renal function) /Ventolin nebulisation* /dialysis*
17 Monitoring Stamp for Patients with Hyperkalemia Date: Time: Monitoring Stamp: To be signed by doctor managing the patient Telemetry or HD or hourly monitoring of vital signs Baseline CBG before IV Insulin bolus Hourly CBG for 6 hours after IV insulin bolus If ECG changes present: o Repeat ECG in 1 hour o Repeat K+ in 2 hours If ECG normal: o Repeat ECG in 4-6 hours o Repeat K+ in 4-6 hours Tick as appropriate Maintenance drip as indicated IV 5%Dextrose or IV Dextrose-Saline
18 Outcome Measures Treatment & Monitoring of Patients with Hyperkalemia Education Protocol, High K pack Monitoring stamp, education Reinforcement Mean: Men: % Compliance Nov-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun11 Jul11 Aug11 Treatment Monitoring
19 Blood Glucose Monitoring Monitoring data Nov 2010 N=9 Jan 2011 N=19 Feb 2011 N=4 March 2011 N=8 April 2011 N=15 May 2011 N=10 June 2011 N=7 July 2011 N=14 Aug 2011 N=15 Blood glucose monitoring Incidence of Hypoglycemia (overall) (CBG < 4mmol/L) 33% 21% 0% 75% 60% 70% 85% 92% 87% 11% 4% 0% 0% 0% 30% 14% 7% 20%
20 Lessons Learned All patients on insulin are at-risk for hypoglycemia because of either errors in insulin dosage or the treatment per se All patients on insulin MUST be monitored for hypoglycemia Team was able to develop an innovative solution by working closely with people on the ground the House Officers and Nurses
21 Thank You!
CONGESTIVE HEART FAILURE PATIENT TEACHING
CONGESTIVE HEART FAILURE PATIENT TEACHING What is Heart Failure? Congestive Heart Failure occurs when the heart loses its ability to pump enough blood to meet the body s needs. Because the heart is not
Provision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine
Provision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine Guideline Updated: August 2010 Replaced: November 1998 To serve the public and guide the medical profession EDTA Chelation
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
ROYAL HOSPITAL FOR WOMEN
ROYAL HOSPITAL FOR WOMEN LOCAL OPERATING PROCEDURE CLINICAL POLICIES, PROCEDURES & GUIDELINES Approved by Quality & Patient Safety Committee 17 April 2014 INSULIN INFUSION PROTOCOL INSULIN DEXTROSE INFUSION
BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY RENAL BIOPSY
1 BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY GUIDELINES ON ADMINISTRATION OF INTRAVENOUS IRON SUCROSE (VENOFER) AS A BOLUS DOSE IN THE RENAL OUTPATIENT SETTING Date Developed: August- October 2007 RENAL
Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes
Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes Nursing home patients with diabetes treated with insulin and certain oral diabetes medications (i.e. sulfonylureas and glitinides) are
ONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)
ADULT INSULIN PRERIPTION AND BLOOD GLUCOSE MONITORING CHART Ward CONSULTANT DATE OF ADMISSION Please affix Patient s label here Ward Ward.../...year PATIENT NAME....... DATE OF BIRTH... NHS NUMBER.......
Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
Specialty Scenarios MED-SURG
MED-SURG TeamSTEPPS 2.0 Specialty - 31 Scenario 26 Clinic Ann Tayner is assigned to work in a busy Internal Medicine Clinic. She recently attended an educational session on infection control techniques
Hypoglycemia (Technician-Paramedic) Protocol revised October 2008
Hypoglycemia (Technician-Paramedic) Protocol revised October 2008 Preamble Prolonged hypoglycemia may result in serious neurologic complications and death. Glucose and glucagon can be administered to correct
Rapid Response Report NPSA/2010/RRR013: Safer administration of insulin
Rapid Response Report NPSA/2010/RRR013: Safer administration of insulin June 2010 Supporting Information Contents 1. Introduction...2 2. Background...2 3. Review of evidence of harm...4 References...7
GESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
GESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION A disorder characterised by hyperglycaemia first recognised during pregnancy due to increased insulin resistance
PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)
ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase
AT&T Global Network Client for Windows Product Support Matrix January 29, 2015
AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 Product Support Matrix Following is the Product Support Matrix for the AT&T Global Network Client. See the AT&T Global Network
Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS
MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,
Crash Cart Drugs Drugs used in CPR. Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University
Crash Cart Drugs Drugs used in CPR Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University Introduction A list of the drugs kept in the crash carts. This list has been approved by the
Guideline for the Management of Acute Hyperkalaemia in Adults
Guideline for the Management of Acute Hyperkalaemia in Adults Author Directorate & Speciality Updated by John Gell (Clinical Pharmacist) Diagnostics and Clinical Support Date of submission April 2013 Date
ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY
Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF
Double pumping of intravenous vasoactive drugs in the critical care setting.
Back to contents Double pumping of intravenous vasoactive drugs in the critical care setting. Approved by & date of Publication Review date September 2006 Lead and contact details * Distribution/ availability
Humulin R (U500) insulin: Prescribing Guidance
Leeds Humulin R (U500) insulin: Prescribing Guidance Amber Drug Level 2 We have started your patient on Humulin R (U500) insulin for the treatment of diabetic patients with marked insulin resistance requiring
Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.
Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Investigational Study Number CLAF237A2386 Title A single-center,
Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
3/26/2015. Debby Kasper, RDN, LDN Director, clinical nutrition Premier, Inc. Cathie Gosnell, RN, MS, MBA Clinical consultant Premier Safety Institute
Debby Kasper, RDN, LDN Director, clinical nutrition Premier, Inc. ENFit enteral connections: Are you ready? Presented by webinar: March 11, 2015 and March 17, 2015 Cathie Gosnell, RN, MS, MBA Clinical
Diabetic Ketoacidosis
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Diabetic Ketoacidosis Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should
SARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE CARE OF THE INTRAPARTUM PATIENT RECEIVING CONTINUOUS INTRAVENOUS INSULIN ADMINISTRATION (obs25) DATE: REVIEWED: PAGES: 9/93 8/15 1 of 7 PS1094 ISSUED
Hyperosmolar Non-Ketotic Diabetic State (HONK)
Hyperosmolar Non-Ketotic Diabetic State (HONK) University Hospitals of Leicester NHS Trust Guidelines for Management of Acute Medical Emergencies Management is largely the same as for diabetic ketoacidosis
Community health care services Alternatives to acute admission & Facilitated discharge options. Directory
Community health care services Alternatives to acute admission & Facilitated discharge options Directory Introduction The purpose of this directory is to provide primary and secondary health and social
Insulin Treatment. J A O Hare. www.3bv.org. Bones, Brains & Blood Vessels
Insulin Treatment J A O Hare www.3bv.org Bones, Brains & Blood Vessels Indications for Insulin Treatment Diabetic Ketoacidosis Diabetics with unstable acute illness ICU Gestational Diabetes: diet failure
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
HYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
Introduction. Background to this event. Raising awareness 09/11/2015
Introduction Primary Care Medicines Governance HSCB Background to this event New class of medicines Availability of training Increasing volume of prescriptions Reports of medication incidents Raising awareness
Upstate University Health System Medication Exam - Version A
Upstate University Health System Medication Exam - Version A Name: ID Number: Date: Unit: Directions: Please read each question below. Choose the best response for each of the Multiple Choice and Medication
Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins)
Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins) I HEAR YA KNOCKING BUT YOU CAN T COME IN (electrolytes) TAKE MY BREATH AWAY (Opiates-morphine) OUT WITH
Anchor Bay School District Diabetic Medical Care Plan. Student Name Date Grade Teacher
Rev: 4/2009 Anchor Bay School District Diabetic Medical Care Plan Place Child s Picture Here Student Name Date Grade Teacher Emergency Contact information (Please list in order to be called) #1 Parent
Note that the following document is copyright, details of which are provided on the next page.
Please note that the following document was created by the former Australian Council for Safety and Quality in Health Care. The former Council ceased its activities on 31 December 2005 and the Australian
Clinical Guideline Diabetes management during surgery (adults)
Clinical Guideline Diabetes management during surgery (adults) Standard 8 of the National Service Framework for Diabetes states that all children, young people and adults with diabetes admitted to hospital,
at The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012
at The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012 Subject - Insulin Safety Background Insulin known to be high risk medication Can promote serious hypoglycemia if given incorrectly
X-Plain Diabetes - Introduction Reference Summary
X-Plain Diabetes - Introduction Reference Summary Introduction Diabetes is a disease that affects millions of Americans every year. Your doctor may have informed you that you have diabetes. Although there
Learning from Defects
Learning from Defects Problem Statement: Healthcare organizations could increase the extent to which they learn from defects. We define learning as reducing the probability that a future patient will be
User guide Basal-bolus Insulin Dosing Chart: Adult
Contacts and further information Local contact Clinical pharmacy or visiting pharmacy Diabetes education service Director of Medical Services Visiting or local endocrinologist or diabetes physician For
Electronic Medication Administration Record (emar) (For Cerner Sites Only)
POLICY NO. 1009 Approved: 12/05 Effective: 12/05 Reviewed: 9/10; 5/12 1. Purpose: Electronic Medication Administration Record (emar) (For Cerner Sites Only) To provide direction for the transcription and
INTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline
Acknowledgements Background Well child with normal hydration Unwell children (+/- abnormal hydration Maintenance Deficit Ongoing losses (e.g. from drains) Which fluid? Monitoring Special Fluids Post-operative
Analysis One Code Desc. Transaction Amount. Fiscal Period
Analysis One Code Desc Transaction Amount Fiscal Period 57.63 Oct-12 12.13 Oct-12-38.90 Oct-12-773.00 Oct-12-800.00 Oct-12-187.00 Oct-12-82.00 Oct-12-82.00 Oct-12-110.00 Oct-12-1115.25 Oct-12-71.00 Oct-12-41.00
SECTION: NM NUMBER: 20. HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs
CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/,
Diabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)
Review Due Date: 2016 May PATIENT CARE ORDERS Weight (kg) Known Adverse Reactions or Intolerances DRUG No Yes (list) FOOD No Yes (list) LATEX No Yes ***See Suggestions for Management (on reverse)*** ***If
NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They
Continuous Quality Improvement using Centricity EMR
Continuous Quality Improvement using Centricity EMR Jamie Howard, MD David A. Nelsen, Jr, MD, MS Associate Professors, UAMS Family & Preventive Medicine Sept 22-25, 2004 CLINICAL INFORMATION SYSTEMS 1
Southern Derbyshire Shared Care Pathology Guidelines. Hyperkalaemia
Southern Derbyshire Shared Care Pathology Guidelines Hyperkalaemia Purpose of Guideline Dealing with adult patients with Hyperkalaemia in the community Definition Serum potassium normal range is 3.5 5.3
Unstoppable Report Removing a Barrier to Patient Flow by Nursing Process Redesign
Unstoppable Report Removing a Barrier to Patient Flow by Nursing Process Redesign 17th Annual Society for Health Systems Management Engineering Forum February 12-13, 2005 Dallas, Texas Norwalk Hospital
CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
Safe use of insulin e- learning module
Safe use of insulin e- learning module Page 1 Introduction Insulin is a hormone produced by the beta cells in the pancreas, it is released when blood glucose levels are raised for example after a meal.
Electronic copy to all appropriate staff Intranet Notification in Staff Focus Related Trust Policies (to be read in conjunction with)
Diabetes Management for Children and Young People undergoing Surgery (0-16 yrs) Clinical Guideline Register No: 10096 Status: Public Developed in response to: Updated national guidelines Contributes to
Objective. Failure Modes & Effects Analysis: A U-500 Insulin Case Study. What is a FMEA? Assembling a Team. Steps to Conducting a FMEA 5/12/2011
5/12/2011 Objective Failure Modes & Effects Analysis: A U-500 Insulin Case Study Understand the role of a failure mode and effects analysis (FMEA) in developing U-500 insulin use criteria Ryan J. Bickel,
Reducing harm from high-alert medications
Institute for Healthcare Improvement s 5 Million Lives Campaign Best-practice protocols: Reducing harm from high-alert medications The Institute for Healthcare Improvement challenges clinicians and administrators
CARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy
Page 1 of 5 INDICATIONS EXCLUSIONS 2 consecutive blood glucose measurements greater than 110 mg per dl AND NPO with a continuous caloric source AND Diagnosis of : Cardio-thoracic Surgery NOTE: This protocol
IN-HOME QUALITY IMPROVEMENT BEST PRACTICE: PHYSICIAN RELATIONSHIPS NURSE TRACK
IN-HOME QUALITY IMPROVEMENT BEST PRACTICE: PHYSICIAN RELATIONSHIPS NURSE TRACK Best Practice Intervention Packages were designed for use by any In-Home Provider Agency to support reducing avoidable hospitalizations
SHINE Study Ordering Instructions for Investigators SUNY Downstate
General Directions SHINE Study Ordering Instructions for Investigators SUNY Downstate 1) Call Spiro Demetis to get patient admitted to ICU ASAP. Cell: 646-261-5730; Pager: 917-760-1653. Let him know that
The New Complex Patient. of Diabetes Clinical Programming
The New Complex Patient as Seen Through the Lens of Diabetes Clinical Programming 1 Valerie Garrett, M.D. Medical Director, Diabetes Center at Mission Health System Nov 6, 2014 Diabetes Health Burden High
Drug Calculations. How to Solve Drug Calculations
S tudent earning entre C Drug Calculations How to Solve Drug Calculations Identify what type of drug calculation and as a first step, use common sense to estimate a rough answer. In many cases, drawing
HEALTH MANAGEMENT PLAN PROGRAMME
HEALTH MANAGEMENT PLAN PROGRAMME Medical Controls for Referees and Candidates The FIVB believes that Referees and Referees Candidates health is very important therefore in accordance with the Medical and
Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA
Journal of Pharmacy and Pharmacology 3 (2015) 33-38 doi: 10.17265/2328-2150/2015.01.005 D DAVID PUBLISHING Evaluation of Glycemic Control with a Pharmacist-Managed Post-Cardiothoracic Surgery Insulin Protocol
Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I
Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Page # 1 Instructions for students: Case study # 1 For this lab, you are planning to provide care to the following client: CB
Replacement post-filter (ml/hr) Blood flow (ml/min) Dialysate (ml/hr) Weight (kg)
404FM.1 CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) USING CITRATE Target Audience: Hospital only ICU (Based on Gambro and Kalmar Hospital protocols) CRRT using regional citrate anticoagulation This is
Medicare Drug Coverage Under Part A, Part B, and Part D
Medicare Drug Coverage Under Part A, Part B, and Part D Medicare Part A and Part B generally do not cover outpatient prescription drugs, most of which are now covered under Part D. This document and the
D( desired ) Q( quantity) X ( amount ) H( have)
Name: 3 (Pickar) Drug Dosage Calculations Chapter 10: Oral Dosage of Drugs Example 1 The physician orders Lasix 40 mg p.o. daily. You have Lasix in 20 mg, 40 mg, and 80 mg tablets. If you use the 20 mg
DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES
Serving the people of north east Essex DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES A Programmed Approach - It is essential you read this pack & practice the questions prior to your drug calculation
[ ] POCT glucose Routine, As needed, If long acting insulin is given and patient NPO, do POCT glucose every 2 hours until patient eats.
Glycemic Control - Insulin Infusion NOTE: For treatment of Diabetic Ketoacidosis or Hyperglycemic Hyperosmolar Syndrome please go to order set named Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar
CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION
SCREENING- ABCD-2 Score The ABCD2 score is a risk assessment tool designed to improve the prediction of short-term stroke risk after a transient ischemic attack (TIA). Higher ABCD2 scores are associated
Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 1 of 138. Exhibit 8
Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 1 of 138 Exhibit 8 Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 2 of 138 Domain Name: CELLULARVERISON.COM Updated Date: 12-dec-2007
University of Gezira. Faculty of Medicine. Department of Paediatrics and Child Health. Integrated Management of Diabetes in Children (IMDC) Project
University of Gezira Faculty of Medicine Department of Paediatrics and Child Health Integrated Management of Diabetes in Children (IMDC) Project Guidelines for Diabetes Management in Children 2007 1 These
Medications or therapeutic solutions may be injected directly into the bloodstream
Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals
CHESHIRE EAST COUNCIL DRIVER MEDICAL
BLOCK LETTERS PLEASE: CHESHIRE EAST COUNCIL DRIVER MEDICAL FULL NAME OF APPLICANT:.. DATE OF BIRTH.... ADDRESS:............. POST CODE... This certificate, which must be completed by a Registered Medical
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Afrezza Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Afrezza (human insulin) Prime Therapeutics will review Prior Authorization requests Prior Authorization
Managing the Hospitalized Patient on Insulin: Care Transition. Catie Prinzing MSN, APRN, CNS
Managing the Hospitalized Patient on Insulin: Care Transition Catie Prinzing MSN, APRN, CNS Diabetes and Hospitalization People with DM are hospitalized 3x more frequently than patients without diabetes
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:
Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures
Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor No disclosures 1 2 3 Discuss data requirements -3 hour bundle -6 hour bundle Challenges and compliance issues Success 4 Based on the Surviving Sepsis
A Guide to Starting. Humalog Mix25
A Guide to Starting Humalog Mix25 This booklet is intended only for those individuals who have been prescribed Humalog Mix 25. It is intended to be used in addition to the Patient Information Leaflet (PIL)
SLIDING SCALE INSULIN ASPART PROTOCOL PLAN
Weight Allergies Patient Care Accucheck Per Sliding Scale Insulin Frequency AC & HS AC & HS 3 days TID BID q12h q6h q6h 24 hr q4h q2h Sliding Scale Insulin Protocol Follow SSI Reference Text Medications
ARIZONA INTRASTATE DIABETES WAIVER PROGRAM
40-1505 R10/14 azdot.gov Dear Applicant: Mail Drop 818Z Medical Review Program PO Box 2100 Phoenix AZ 85001-2100 ARIZONA INTRASTATE DIABETES WAIVER PROGRAM Thank you for your interest in the Arizona Intrastate
What Is Patient Safety?
Patient Safety Research Introductory Course Session 1 What Is Patient Safety? David W. Bates, MD, MSc External Program Lead for Research, WHO Professor of Medicine, Harvard Medical School Professor of
Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE
CME Accreditation is under process Module 1: Diabetes Facts and Diabetes in the Clinic Module 2: Nursing theory and educational (pedagogical) tools to advise and educate people with diabetes and their
Diabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
ENROLLED NURSE GRADUATE PROGRAM: BENDIGO HEALTH. Dr Helen Aikman Manager of Nursing and Midwifery Education
ENROLLED NURSE GRADUATE PROGRAM: BENDIGO HEALTH Dr Helen Aikman Manager of Nursing and Midwifery Education Insert title The need: Most professions have identified that early graduates need support Professional
National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment
NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient
Management of Diabetes Mellitus in Custody
Recommendations The medico-legal guidelines and recommendations published by the Faculty are for general information only. Appropriate specific advice should be sought from your medical defence organisation
BEHAVIORAL HEALTH AND DETOXIFICATION - MEETING DEMAND FOR SERVICES UNIVERSITY OF PITTSBURGH MEDICAL CENTER MERCY HOSPITAL Publication Year: 2013
BEHAVIORAL HEALTH AND DETOXIFICATION - MEETING DEMAND FOR SERVICES UNIVERSITY OF PITTSBURGH MEDICAL CENTER MERCY HOSPITAL Publication Year: 2013 Summary: The development of separate intake area for behavioral
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
Procedure for Inotrope Administration in the home
Procedure for Inotrope Administration in the home Purpose This purpose of this procedure is to define the care used when administering inotropic agents intravenously in the home This includes: A. Practice
Skills Standards ADVANCED CMA: INSULIN ADMINISTRATION OD68609 MEETS OSDH NURSE AIDE REGISTRY CERTIFICATION REQUIREMENTS
Skills Standards ADVANCED CMA: INSULIN ADMINISTRATION OD68609 MEETS OSDH NURSE AIDE REGISTRY CERTIFICATION REQUIREMENTS COMPETENCY-BASED EDUCATION: OKLAHOMA S RECIPE FOR SUCCESS BY THE INDUSTRY FOR THE
Patient Care Services Quality Report Evaluation of 2013 Outcomes August 2014
Patient Care Services Quality Report Evaluation of 2013 Outcomes August 2014 Submitted by, Carol A Dwyer, MSN, MM, RN, CENP Vice President, Patient Care Services Chief Nursing Officer 1 Index INTRODUCTION...3
Should Insulin be added to Parenteral Nutrition?
ESPEN Congress Gothenburg 2011 Educational Session - Pharmaceutical session (in collaboration with ASPEN) Should Insulin be added to Parenteral Nutrition? Jay M Mirtallo Should Insulin be added to Parenteral
Cardiac Arrest - Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008
Cardiac Arrest - Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008 Preamble Survival from cardiorespiratory arrest for patients who present with ventricular fibrillation
